EORTC abstracts selected at ESMO 2019
18 Sep 2019
In total, EORTC will be presenting 3 abstracts (2 oral presentations and 1 poster) at the ESMO Congress 2019 from 27 September until 1 October in Barcelona, Spain.
Andrew Bottomley, Head of the Quality of Life at EORTC, will chair a session about “Surviving a cancer diagnosis with a good QoL” on 30 September from 8:30 to 10:00 and give a lecture on “Can value frameworks (such as ESMO-MCBS) contribute to a higher QoL?”
During the same session, Madeline Pe, EORTC Specialist in QoL, will talk about EORTC’s work on survivorship.
Meet us at our booth located in the society village n°20.
Oral presentations
A phase II study of Monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R Galot, C Le Tourneau, E Saada-Bouzid, A Daste, C Even, P Debruyne, S Henry, S Zanetta, A Rutten, L Licitra, JL Canon, MC Kaminsky, P Specenier, S Rottey, L Dirix, T Raveloarivahy, C Fortpied, M Vanlancker, A Govaerts, JP Machiels
Presentation number: 1109O
Speaker: Rachel Galot
Date: 30.09.2019 – Lecture time: 10:15 – 11:45 – Location: Cordoba Auditorium (Hall 7)
Redefining the IGCCCG Classification in advanced Non-Seminoma
Gillessen S, Collette L, Daugaard G, De Wit R, Tryakin A, Albany C, Stahl O, Fizazi K, Gietema J, De Giorgi U, Hansen AR, Feldman D, Cafferty FH, Tandstad T, Garcia del Muro X, Huddart R, Sweeney C, Heng DY, Sauvé N and Beyer J for the IGCCCG Update Consortium
Presentation number: 903O
Speaker: Silke Gillessen
Date: 28.09.2019 – Lecture time: 15:30 – 15:45 – Location: Sevilla Auditorium (Hall 2)
Poster
There is a lack of clinical research for patients with cancer in palliative care
M. Vinches, A. Neven, L. Fenwarth, M. Terada, G. Rossi, S. Kelly, J. Peron, M. Thomaso, M. Groenvold, T. De Rojas
Poster number: 1610P
Poster presenter: Marie Vinches
Date: 28.09.2019 – Lecture time: 12:20 – Location: Poster Area (Hall 4)
Related News
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
